 Home > Medical News > Latest Medical News > Pioneer Pharmaceuticals Prokalamide's Phase III clinical trial for the treatment of COVID-19 was approved by Brazil's ANVISA

Pioneer Pharmaceuticals Prokalamide's Phase III clinical trial for the treatment of COVID-19 was approved by Brazil's ANVISA

 Last Update: 2021-06-22
 Source: Internet
 Author: User

Tags

daliresp drug class

new materials

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On June 15, 2021, Kaifeng Pharmaceutical Co.
, Ltd.
announced that its Phase III clinical trial of Prokalamide for the treatment of male patients with mild and moderate new coronary disease has been formally approved by the Brazilian drug regulatory agency ANVISA on June 11, local time
.

This is also the third phase III clinical trial of Pioneer Pharmaceuticals for the treatment of COVID-19 after the U.

It is reported that the study (NCT04869228) is a randomized, double-blind, placebo-controlled, global multi-center phase III clinical trial, which aims to explore the effectiveness and safety of procrulamide in the treatment of male patients with mild and moderate new coronary disease
.

The primary endpoint of the clinical trial is the percentage of subjects who require oxygen in 28 days

Note: The original text has been deleted

Reference materials:

[1] Open up the WeChat public account of the pharmaceutical industry

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.